Dr Eswar Shankar has a PhD and is a Cancer Biologist, faculty at the Division of Medical Oncology Division, Department of Internal Medicine, Wexner Medical Center, Ohio State University, United States. He is funded by the Department of Defense to study the combinatorial efficacy of drugs to target EZH2 and inhibit Triple Negative Breast Cancer Growth and Metastasis. Dr Shankar has 15 years of research experience in the field of biochemistry, and cell & molecular biology, managing projects independently and in a team, to his credit has 36 research articles, 7 reviews, and 4 book chapters. He works in multi-cultural as well as cross-functional research groups. He has also experience performing research with natural products and their role in cancer growth and metastasis.
Biography
Dr Eswar Shankar has a PhD and is a Cancer Biologist, faculty at the Division of Medical Oncology Division, Department of Internal Medicine, Wexner Medical Center, Ohio State University, United States. He is funded by the Department of Defense to study the combinatorial efficacy of drugs to target EZH2 and inhibit Triple Negative Breast Cancer Growth and Metastasis. Dr Shankar has 15 years of research experience in the field of biochemistry, and cell & molecular biology, managing projects independently and in a team, to his credit has 36 research articles, 7 reviews, and 4 book chapters. He works in multi-cultural as well as cross-functional research groups. He has also experience performing research with natural products and their role in cancer growth and metastasis.
Contact Form